About Degradable Solutions
Degradable Solutions is a company based in Zurich (Switzerland) founded in 1999 was acquired by Collagen Matrix in December 2020. Degradable Solutions operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Zurich, Switzerland
- SectorsHealthcareChemicals & Materials
- PhoneLocked
- WebsiteLocked
- Annual RevenueNot available
- Net ProfitNot available
- EBITDANot available
- Latest Funding RoundNot available
- Investors
- Employee CountNot available
- Acquired byCollagen Matrix
(Dec 29, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Degradable Solutions
Detailed funding history for Degradable Solutions
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Degradable Solutions
Degradable Solutions has secured backing from 1 investor. Prominent investors backing the company include Collagen Matrix.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Collagen and mineral based medical devices | Locked | Locked | Locked |
Investor details for Degradable Solutions
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Degradable Solutions
Investment portfolio details for Degradable Solutions
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Degradable Solutions
Detailed financials for Degradable Solutions
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Degradable Solutions Comparisons
Peer comparison for Degradable Solutions
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Degradable Solutions
Degradable Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked | Developer of pharmaceuticals and vaccines for various therapeutic areas | |
| Locked | Locked | Locked | Antibody-siRNA complexes are developed for cancer treatment. | |
| Locked | Locked | Locked | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| Locked | Locked | Locked | Yeast cells are genetically engineered to produce medicinal products. | |
| Locked | Locked | Locked | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| Locked | Locked | Locked | CRISPR-engineered cell and gene therapies are developed for research applications. |
Detailed competitors of Degradable Solutions
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Degradable Solutions
Complete news archive for Degradable Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Degradable Solutions
Degradable Solutions was founded in 1999.
Degradable Solutions is headquartered in Zurich, Switzerland.
Degradable Solutions was established in 1999 as a spin-off from ETH Zurich, Switzerland, where operations are based. Focus is placed on the biomedical sector, with synthetic bone graft substitutes produced under the GUIDOR brand. Key offerings include easy-graft, a hardening filler of bioceramics and biopolymers; Calc-i-oss variants for bone regeneration; Calc-i-pur Ξ²-TCP mineral powder; and resorbable membranes that support fluid exchange while blocking soft tissue growth.
Degradable Solutions's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Degradable Solutions has 1 investor. Key investors include Collagen Matrix.